Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for OC-02 nasal spray (The PEARL Study) evaluating efficacy in signs and symptoms of Dry Eye Disease; study status completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OC-02 nasal spray (OC-02)

Snippet

Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-12-14